Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.680
+0.410 (12.54%)
At close: Jan 17, 2025, 4:00 PM
3.690
+0.010 (0.27%)
After-hours: Jan 17, 2025, 6:35 PM EST
Revance Therapeutics Market Cap
Revance Therapeutics has a market cap or net worth of $386.04 million as of January 21, 2025. Its market cap has decreased by -49.00% in one year.
Market Cap
386.04M
Enterprise Value
685.41M
1-Year Change
-49.00%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $453.20M to $386.04M, a decrease of -14.82%. That is a compound annual growth rate of -1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 386.00M | 21.04% |
| Dec 31, 2024 | 318.90M | -58.69% |
| Dec 29, 2023 | 771.90M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 157.62% |
| Dec 31, 2019 | 732.10M | -1.68% |
| Dec 31, 2018 | 744.60M | -32.67% |
| Dec 29, 2017 | 1.11B | 87.35% |
| Dec 30, 2016 | 590.30M | -38.42% |
| Dec 31, 2015 | 958.60M | 138.58% |
| Dec 31, 2014 | 401.80M | -11.34% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |